Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics
What Is the Current Size and Annual Growth Rate of the Non-Hormonal Contraceptives Market?
The non-hormonal contraceptives market size has grown strongly in recent years. It will grow from $23.73 billion in 2024 to $25.47 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to growing support for women’s health initiatives, growing availability of over-the-counter non-hormonal contraceptive options, increasing focus on male contraceptive product development, rising demand for fertility-awareness-based contraceptive solutions, and growing number of product approvals and launches in non-hormonal space.
The non-hormonal contraceptives market size is expected to see strong growth in the next few years. It will grow to $33.48 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing demand for hormone-free birth control alternatives, rising awareness of side effects associated with hormonal contraceptives, growing preference for natural and chemical-free contraceptive methods, increasing prevalence of sexually transmitted diseases, and rising health consciousness among women regarding reproductive health. Major trends in the forecast period include advancements in biomaterials for non-hormonal contraceptive devices, technology-driven innovation in barrier contraceptive design, integration of smart tracking features with fertility-awareness methods, advancements in drug-free contraceptive gels and films, and technology-enabled self-administration tools for contraceptive devices.
Get your free report sample today:
Which Core Market Drivers Are Influencing the Development of the Non-Hormonal Contraceptives Market?
The growing prevalence of sexually transmitted diseases is expected to propel the growth of the non-hormonal contraceptives market going forward. Sexually transmitted diseases (STDs) are infections mainly spread through sexual contact and caused by bacteria, viruses, or parasites. The increase in sexually transmitted diseases is largely attributed to a decline in condom usage, raising the likelihood of infection during unprotected sex. Non-hormonal contraceptives, including male and female condoms, help prevent the transmission of sexually transmitted diseases by serving as a physical barrier that prevents the exchange of bodily fluids during sexual activity. For instance, in April 2025, according to the Minnesota Department of Health (MDH), a US-based state health agency, the proportion of HIV cases among males aged 35 to 39 increased from 10% in 2023 to 17% in 2024. Therefore, the growing prevalence of sexually transmitted diseases is driving the growth of the non-hormonal contraceptives market.
Which Market Segment Offers the Most Significant Growth Opportunities in the Non-Hormonal Contraceptives Market?
The non-hormonal contraceptives market covered in this report is segmented –
1) By Type: Devices, Sterilization, Other Product Types
2) By Mechanism Of Action: Antagonist, Agonist, Inhibitor, Modulator
3) By Route of Administration: Intramuscular, Intravaginal, Intravenous, Oral, Subcutaneous, Topical, Transdermal, Other Route Of Administrations
4) By Purpose Of Therapy: Treatment Of Disease, Management Of Symptoms
5) By Target Indication: Bacterial Vaginosis, Contraception, Endometriosis, Postmenopausal Osteoporosis, Uterine Fibroids, Vaginitis, Other Target Indications
Subsegments:
1) By Devices: Surgical Instruments, Ligation Clips, Tubal Rings
2) By Sterilization: Permanent Sterilization, Reversible Sterilization, Mechanical Sterilization Devices
3) By Other Product Types: Non-Surgical Barrier Devices, Implantable Plugs, Intrauterine Permanent Devices
What New Market Trends Are Emerging in the Non-Hormonal Contraceptives Market?
Major companies operating in the non-hormonal contraceptives market are focusing on developing innovative solutions such as preloaded intrauterine device delivery systems to simplify insertion procedures, enhance user convenience, and improve clinical efficiency. A preloaded intrauterine device (IUD) delivery system refers to a pre-assembled, ready-to-use device that integrates the preloaded intrauterine device and its inserter into a single unit, designed to streamline the insertion process, reduce setup time, and minimize the risk of contamination or handling mistakes. For instance, in September 2024, CooperSurgical Inc., a US-based medical device and fertility company, introduced the Paragard Single-Handed Inserter, aimed at enhancing insertion efficiency and patient comfort during non-hormonal preloaded intrauterine device placement. It offers over 99% effective, long-term birth control for up to 10 years by preventing sperm from fertilizing an egg. Key benefits include immediate and reversible contraception, hormone-free suitability, and low maintenance once inserted.
Who Are the Top Performers and Innovators in the Non-Hormonal Contraceptives Market?
Major companies operating in the non-hormonal contraceptives market are Bayer AG., Church & Dwight Co., Mankind Pharma Limited, Okamoto Industries, CooperSurgical Inc., PSI India Pvt Ltd., Karex Berhad, Natural Cycles Nordic AB, Fuji Latex Co. Ltd., PREGNA INTERNATIONAL LTD., Cupid Limited, Veru Inc., Evofem Biosciences Inc., Daré Bioscience Inc., Global Protection Corp., SMB Corporation of India, HLL Lifecare Limited, YourChoice Therapeutics Inc., Cirqle Biomedical Contraception ApS, Eppin Pharma Inc., Contraline Inc., Linepharma International Ltd.
Get the detailed non-hormonal contraceptives market report today
Which Regional Markets Are Likely to See the Most Significant Expansion in the Coming Years?
North America was the largest region in the non-hormonal contraceptives market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-hormonal contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment